Share
4,150 Posts.
lightbulb Created with Sketch. 59
clock Created with Sketch.
19/11/17
14:30
Share
Originally posted by gingerclam
↑
I don't know about you but at the moment I'm reading quite a bit of positivity in the HC threads amongst the junior biotechs.
2018 could be a stella year for the 'Juniors' and firmly expecting that NEU will lead the charge but the likes of PNV, PYC and AHZ to be swept along in their own unfolding stories, commercially for PNV and AHZ and in further research collaborations for PYC.
PNV is going to be a cracking success 12 months from here...following David Williams (PNV, MVP) and Richard Treagus (NEU, BTC) and what they might do next is, well, you could do a lot worse (and I have)...
But for right now - it's ALL NEU ...
Good luck DYOR - but be quick about it.
Expand
Been along time between drinks here , the Bio Gene listing later this month will be a good litmus test of market opinion on the sector , been some real dissapointments throughout the year .